Regulatory Focus™ > News Articles > Rule would Require Device, Drug Firms to Report Payments to Providers

Rule would Require Device, Drug Firms to Report Payments to Providers

Posted 21 December 2011 | By

The Centers for Medicare & Medicaid Services (CMS) issued a Sunshine Law proposal requiring health care manufacturers to report all gifts and payments to doctors and teaching hospitals to a public database.  As part of health reforms contained in the Affordable Care Act, the proposed rule would require med-tech makers as well as drug, biologicals, medical supplies manufacturers and group purchasing organizations to keep records of payments and other values transferred to doctors and teaching hospitals.  The rule would also require manufacturers and GPOs to disclose physician ownership or investment interests, including those held by immediate family members. 

The agency plans to publics all records to a public website, where it will be downloadable, searchable and easily aggregated. In addition, CMS plans to submit annual reports to Congress and each state summarizing the data.  CMS hopes to finalize the rule as soon as possible and may require a preliminary report from manufacturers by 31 March, 2013. The agency doesn't plan to ask manufacturers to begin collecting data until it issues a final rule.  The proposal is open for public comment until 17 February, 2012. (Mass Device)

Tags: GPOs, Sunshine, CMS

Regulatory Focus newsletters

All the biggest regulatory news and happenings.